Chambery

France

59 total trials 25 recruiting

Filter these 59 trials by phase, condition, sponsor and more.

Open in Search →

PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection Ended recruitment

2024-510704-37-00 5 2017-03-22 ER+/HER2- metastatic breast cancer
A Phase Ib-II Study of tazemetostat (EPZ-6438) in newly diagnosed Diffuse Large B Cell Lymphoma (DLBCL) or high risk Follicular Lymphoma (FL … Ended recruitment

2024-515846-18-00 7 2016-09-19 Newly diagnosed Diffuse Large B Cell Lymphoma
PRODIGE 34 - ADAGE: Randomised phase III study evaluating adjuvant chemotherapy after resection of stage III colon adenocarcinoma in patient … Ended recruitment

2024-518741-21-00 4 2014-12-23 colon cancer
A large-scale comparative study evaluating an intravenous treatment, cabazitaxel, and radiation therapy to the pelvic lymph nodes in patient … Ended recruitment

2024-517622-25-00 5 2013-12-06 Patients with localized prostate cancer and high-risk features of rela
A randomized, open-label, controlled phase III trial comparing the pembrolizumab platinum based chemotherapy combination with pembrolizumab … Ended

2024-513697-22-00 5 2024-11-07 non-small-cell lung cancer
An 18-month study to assess joint outcomes in patients with haemophilia A or B on prophylaxis with efmoroctocog alfa or eftrenonacog alfa Ended

2022-502921-16-00 6 2023-07-21 Hemophilia A and B
Study to understand if inclisiran is better than a placebo at lowering LDL-cholesterol,is safe and can have an impact on patient quality of … Ended

2024-511263-28-00 6 2022-04-08 Hypercholesterolemia
EFRAIM II _ Empirical steroids and/or antifungals treatment of immunocompromised patients with acute respiratory failure of uknown origin: a … Ended

2024-514344-82-00 5 2021-02-18 patients with acute respiratory failure from undetermined etiology
Trial comparing the continuation of nivolumab and ipilimumab (doublet immunotherapy) to observation after a first 6 months treatment by nivo … Ended

2024-514586-20-01 5 2018-05-02 Non small cell lung cancer
A Study to Evaluate the Efficacy and Safety of Polatuzumab Vedotin in Combination with Rituximab and CHP (R-CHP) Versus Rituximab and CHOP ( … Ended

2024-516904-40-00 5 2018-03-27 Previously Untreated Diffuse large B-cell lymphoma (DLBCL)
A Phase III Prospective Double Blind Placebo Controlled Randomized Study of Adjuvant MEDI4736 in Completely Resected Non-Small Cell Lung Can … Ended

2024-517856-36-00 5 2015-03-09 Completely resected primary stage IB (≥ 4cm), II and IIIA non-small ce

Showing 49–59 of 59 trials